164 related articles for article (PubMed ID: 11900766)
1. 5-HT2A receptor-stimulated phosphoinositide hydrolysis in the stimulus effects of hallucinogens.
Rabin RA; Regina M; Doat M; Winter JC
Pharmacol Biochem Behav; 2002 May; 72(1-2):29-37. PubMed ID: 11900766
[TBL] [Abstract][Full Text] [Related]
2. Characterisation of human 5-hydroxytryptamine2A and 5-hydroxytryptamine2C receptors expressed in the human neuroblastoma cell line SH-SY5Y: comparative stimulation by hallucinogenic drugs.
Newton RA; Phipps SL; Flanigan TP; Newberry NR; Carey JE; Kumar C; McDonald B; Chen C; Elliott JM
J Neurochem; 1996 Dec; 67(6):2521-31. PubMed ID: 8931486
[TBL] [Abstract][Full Text] [Related]
3. Dihydrobenzofuran analogues of hallucinogens. 4. Mescaline derivatives.
Monte AP; Waldman SR; Marona-Lewicka D; Wainscott DB; Nelson DL; Sanders-Bush E; Nichols DE
J Med Chem; 1997 Sep; 40(19):2997-3008. PubMed ID: 9301661
[TBL] [Abstract][Full Text] [Related]
4. Role of 5-HT2A and 5-HT2C receptors in the stimulus effects of hallucinogenic drugs. II: Reassessment of LSD false positives.
Fiorella D; Rabin RA; Winter JC
Psychopharmacology (Berl); 1995 Oct; 121(3):357-63. PubMed ID: 8584618
[TBL] [Abstract][Full Text] [Related]
5. Effect of ring fluorination on the pharmacology of hallucinogenic tryptamines.
Blair JB; Kurrasch-Orbaugh D; Marona-Lewicka D; Cumbay MG; Watts VJ; Barker EL; Nichols DE
J Med Chem; 2000 Nov; 43(24):4701-10. PubMed ID: 11101361
[TBL] [Abstract][Full Text] [Related]
6. Lysergic acid diethylamide and 2,5-dimethoxy-4-methylamphetamine are partial agonists at serotonin receptors linked to phosphoinositide hydrolysis.
Sanders-Bush E; Burris KD; Knoth K
J Pharmacol Exp Ther; 1988 Sep; 246(3):924-8. PubMed ID: 2843634
[TBL] [Abstract][Full Text] [Related]
7. Contribution of a helix 5 locus to selectivity of hallucinogenic and nonhallucinogenic ligands for the human 5-hydroxytryptamine2A and 5-hydroxytryptamine2C receptors: direct and indirect effects on ligand affinity mediated by the same locus.
Almaula N; Ebersole BJ; Ballesteros JA; Weinstein H; Sealfon SC
Mol Pharmacol; 1996 Jul; 50(1):34-42. PubMed ID: 8700116
[TBL] [Abstract][Full Text] [Related]
8. Investigation of hallucinogenic and related beta-carbolines.
Grella B; Dukat M; Young R; Teitler M; Herrick-Davis K; Gauthier CB; Glennon RA
Drug Alcohol Depend; 1998 Apr; 50(2):99-107. PubMed ID: 9649961
[TBL] [Abstract][Full Text] [Related]
9. Comparison of the discriminative stimulus effects of dimethyltryptamine with different classes of psychoactive compounds in rats.
Gatch MB; Rutledge MA; Carbonaro T; Forster MJ
Psychopharmacology (Berl); 2009 Jul; 204(4):715-24. PubMed ID: 19288085
[TBL] [Abstract][Full Text] [Related]
10. A comparison of N,N-dimethyltryptamine, harmaline, and selected congeners in rats trained with LSD as a discriminative stimulus.
Helsley S; Fiorella D; Rabin RA; Winter JC
Prog Neuropsychopharmacol Biol Psychiatry; 1998 May; 22(4):649-63. PubMed ID: 9682278
[TBL] [Abstract][Full Text] [Related]
11. Correlation between the potency of hallucinogens in the mouse head-twitch response assay and their behavioral and subjective effects in other species.
Halberstadt AL; Chatha M; Klein AK; Wallach J; Brandt SD
Neuropharmacology; 2020 May; 167():107933. PubMed ID: 31917152
[TBL] [Abstract][Full Text] [Related]
12. 5-HT2C receptor-mediated phosphoinositide turnover and the stimulus effects of m-chlorophenylpiperazine.
Fiorella D; Helsley S; Rabin RA; Winter JC
Psychopharmacology (Berl); 1995 Dec; 122(3):237-43. PubMed ID: 8748393
[TBL] [Abstract][Full Text] [Related]
13. Agonist properties of N,N-dimethyltryptamine at serotonin 5-HT2A and 5-HT2C receptors.
Smith RL; Canton H; Barrett RJ; Sanders-Bush E
Pharmacol Biochem Behav; 1998 Nov; 61(3):323-30. PubMed ID: 9768567
[TBL] [Abstract][Full Text] [Related]
14. The role of the 5-HT2A and 5-HT2C receptors in the stimulus effects of hallucinogenic drugs. I: Antagonist correlation analysis.
Fiorella D; Rabin RA; Winter JC
Psychopharmacology (Berl); 1995 Oct; 121(3):347-56. PubMed ID: 8584617
[TBL] [Abstract][Full Text] [Related]
15. Hallucinogen-like actions of 2,5-dimethoxy-4-(n)-propylthiophenethylamine (2C-T-7) in mice and rats.
Fantegrossi WE; Harrington AW; Eckler JR; Arshad S; Rabin RA; Winter JC; Coop A; Rice KC; Woods JH
Psychopharmacology (Berl); 2005 Sep; 181(3):496-503. PubMed ID: 15983786
[TBL] [Abstract][Full Text] [Related]
16. Choroid plexus epithelial cells in primary culture: a model of 5HT1C receptor activation by hallucinogenic drugs.
Sanders-Bush E; Breeding M
Psychopharmacology (Berl); 1991; 105(3):340-6. PubMed ID: 1665919
[TBL] [Abstract][Full Text] [Related]
17. (+)Lysergic acid diethylamide, but not its nonhallucinogenic congeners, is a potent serotonin 5HT1C receptor agonist.
Burris KD; Breeding M; Sanders-Bush E
J Pharmacol Exp Ther; 1991 Sep; 258(3):891-6. PubMed ID: 1679849
[TBL] [Abstract][Full Text] [Related]
18. The role of the 5-HT2A and 5-HT2C receptors in the stimulus effects of hallucinogenic drugs. III: The mechanistic basis for supersensitivity to the LSD stimulus following serotonin depletion.
Fiorella D; Helsley S; Lorrain DS; Rabin RA; Winter JC
Psychopharmacology (Berl); 1995 Oct; 121(3):364-72. PubMed ID: 8584619
[TBL] [Abstract][Full Text] [Related]
19. LSD and the phenethylamine hallucinogen DOI are potent partial agonists at 5-HT2A receptors on interneurons in rat piriform cortex.
Marek GJ; Aghajanian GK
J Pharmacol Exp Ther; 1996 Sep; 278(3):1373-82. PubMed ID: 8819525
[TBL] [Abstract][Full Text] [Related]
20. Stimulus generalization by fenfluramine in a quipazine-ketanserin drug discrimination is not dependent on indirect serotonin release.
Smith RL; Gresch PJ; Barrett RJ; Sanders-Bush E
Pharmacol Biochem Behav; 2002 May; 72(1-2):77-85. PubMed ID: 11900772
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
